...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Structure-based design of nitrosoureas containing tyrosine derivatives as potential antimelanoma agents.
【24h】

Structure-based design of nitrosoureas containing tyrosine derivatives as potential antimelanoma agents.

机译:含酪氨酸衍生物作为潜在的anlanlanoma剂的亚硝基脲的基于结构的设计。

获取原文
获取原文并翻译 | 示例
           

摘要

Two new nitrosoureas (TNUs), containing tyrosine derivatives as carriers of nitrosourea cytotoxic group have been synthesised. The physicochemical properties such as half-life time (tau(0.5)), alkylating and carbamoylating activities were determined. The nitrosoureas showed a higher inhibiting effect on the DOPA-oxidase activity of mushroom tyrosinase than that of the antitumour drug N'-cyclohexyl-N-(2-chloroethyl)-N-nitrosourea (lomustine, CCNU). In vitro cytotoxic effects of newly synthesised tyrosine containing nitrosoureas have been studied and compared to those of CCNU. A higher cytotoxicity to B16 melanoma cells than to YAC-1 and to lymphocytes was demonstrated for the tyrosine containing nitrosoureas in comparison with CCNU. Based on the results presented, we accept that a new trend for synthesis of more selective and less toxic nitrosourea derivatives as potential antimelanomic drugs might be developed.
机译:合成了两个新的亚硝基脲(TNU),其中含有酪氨酸衍生物作为亚硝基脲细胞毒性基团的载体。确定其物理化学性质,例如半衰期(tau(0.5)),烷基化和氨基甲酰化活性。亚硝基脲比抗肿瘤药N'-环己基-N-(2-氯乙基)-N-亚硝基脲(洛莫司汀,CCNU)对蘑菇酪氨酸酶的DOPA氧化酶活性具有更高的抑制作用。已经研究了新合成的含酪氨酸的亚硝基脲的体外细胞毒性作用,并与CCNU进行了比较。与CCNU相比,含酪氨酸的亚硝基脲对B16黑色素瘤细胞的毒性比对YAC-1和淋巴细胞的毒性更高。根据提出的结果,我们接受合成具有更高选择性和更低毒性的亚硝基脲衍生物的新趋势,因为它可能会发展成为一种抗代谢药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号